The document discusses the importance of innovation and collaboration in the NHS, emphasizing the need for strong partnerships between local businesses and healthcare providers to enhance patient care and reduce variation in service delivery. It outlines strategies for product development in the pharmaceutical industry, the role of clinicians in value assessment, and highlights case studies demonstrating successful collaboration. Additionally, it addresses challenges faced by clinical commissioning groups (CCGs) in federating to achieve strategic change and improving healthcare outcomes.

1. PM Society NHS Partnerships Group
Mark Wilkinson - Director Life Sciences Innovation, Interim
Chief Officer (Darlington CCG), Interim Managing Director
(Durham Dales Easington and Sedgefield CCG)
18 April 2012

2. Innovation and Collaboration
• Look out not up.
1
• Local business to
2 business relationship.
• „Next steps‟ we can take.
3

3. (NHS) Language matters

4. The old paradigm?
Product
development -
Industry
Value
Implementation
assessment –
– clinicians and
NHS bodies HTA bodies
and regulators

5. Evidence shows us we innovate together
Skills for innovation Organisational factors
1st Creativity 1st Attract and retain qualified
2nd Ability to collaborate people
2nd R&D investment
3rd Customer communication
4th Strong supplier relationships
Innovation requires
collaboration and strong
connections to customers /
suppliers

6. The emerging paradigm?
Product
development
Value
Implementation
assessment

7. Innovation and collaboration
1 • Look out not up.

8. Product development
Pharma industry led initiative
using Tapestry Networks
European Healthcare
Innovation Leadership Network
Clinician led value frameworks
for conditions
www.tapestrynetworks.com/progress/health
care-innovation-case-study.cfm

9. NHS quality improvement system
Domain 1 Domain 2 Domain 3 Domain 4 Domain 5
Preventing Enhancing Helping people to Ensuring that Treating and caring
people from quality of Life recover from people have a for people in a safe
dying for people episodes of ill positive environment and
with long- health or following experience of protecting them
prematurely
term injury care from avoidable
conditions harm.
NICE Quality standards
(Building a library of approx 150 over 5 years)
Provider payment mechanisms
Commissioning Commissioning
Outcomes Guidance Standard
Tariff CQUIN QOF
Framework Contract

10. Innovation Health and Wealth
Reducing Creating a
variation system for Incentives and
strengthening innovation investment
compliance delivery
Developing our High impact
Procurement
people innovations

11. Mike Farrar
“I‟m a big fan … principle of clinical
commissioning … GPs will micro commission
very well, improving individual pathways, and
challenging referrals, can they convert small
pockets of gain into „right-sizing‟ of the
providers? … So the challenge for the CCGs
is: can they federate to achieve strategic
change? Will they be able to work
collaboratively with the NHS Commissioning
Board?”

12. Drug Reps soften sales pitch –
will they still buy the cream cakes?
nhsmanagers.net

13. Building Trust: Contact
‘The 5 Cs’
Collaboration Clarity
Confidence Communication

14. Eight industry case studies
Industry concerns:
• Local restrictions at odds with NICE appraisal or
guidance,
• Local burdensome administration being introduced
with the aim of reducing uptake,
• Local reinterpretation of MHRA / NICE appraisal or
guidance.

15. Observations
Little evidence of local discussion on the
issues.
Lack of information on the uptake of NICE
reviewed medicines.
Through discussion we shared and improved
our knowledge.

16. Describing a
Business to
Trust,
Business co-working,
Relationship shared vision,
integrity
Shared value exchange,
Understand strategy, Contact
at all levels across all functions,
Understand needs, do what you say,
solve my problems, access, personal
contact

17. Innovation and collaboration
• Look out not up.
1
• Local business to
2 business relationship.

18. How it’s happening
Products Close Skills
and services connections exchange

19. St Helens PBC and GSK
Higher prevalence / 9% fall in
admissions
Higher patient satisfaction
Higher NICE compliance with less GP
variation

20. Promoting collaboration
• Promoting examples: NHS
Networks / Wellards
• Avoiding naïve
transplantationism
• Wider than joint working
• Risk shares and value based
pricing

21. Ten priorities for commissioners
• Medication reviews so prescribing standards are met.
• Decision-support tools support best practice
• Clinicians providing educational info.
• Pharmacy technicians support practices
• Safe transfer of patient medication information at
admission and discharge
• Benchmarked information on prescribing performance
www.kingsfund.org.uk

22. Innovation and collaboration
• Look out not up.
1
• Local business to
2 business relationship.
• „Next steps‟ we can take.
3
mark.wilkinson@northwest.nhs.uk